203 related articles for article (PubMed ID: 14615376)
21. Atypical X-linked SCID phenotype associated with growth hormone hyporesponsiveness.
Ursini MV; Gaetaniello L; Ambrosio R; Matrecano E; Apicella AJ; Salerno MC; Pignata C
Clin Exp Immunol; 2002 Sep; 129(3):502-9. PubMed ID: 12197892
[TBL] [Abstract][Full Text] [Related]
22. Constitutive association of JAK1 and STAT5 in pro-B cells is dissolved by interleukin-4-induced tyrosine phosphorylation of both proteins.
Erhardt I; Lischke A; Sebald W; Friedrich K
FEBS Lett; 1998 Nov; 439(1-2):71-4. PubMed ID: 9849880
[TBL] [Abstract][Full Text] [Related]
23. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
[TBL] [Abstract][Full Text] [Related]
24. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
25. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R
Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786
[TBL] [Abstract][Full Text] [Related]
26. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency.
Candotti F; Johnston JA; Puck JM; Sugamura K; O'Shea JJ; Blaese RM
Blood; 1996 Apr; 87(8):3097-102. PubMed ID: 8605322
[TBL] [Abstract][Full Text] [Related]
27. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene.
Taylor N; Uribe L; Smith S; Jahn T; Kohn DB; Weinberg K
Blood; 1996 Apr; 87(8):3103-7. PubMed ID: 8605323
[TBL] [Abstract][Full Text] [Related]
28. Deep intronic mis-splicing mutation in JAK3 gene underlies T-B+NK- severe combined immunodeficiency phenotype.
Stepensky P; Keller B; Shamriz O; NaserEddin A; Rumman N; Weintraub M; Warnatz K; Elpeleg O; Barak Y
Clin Immunol; 2016 Feb; 163():91-5. PubMed ID: 26769277
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
[TBL] [Abstract][Full Text] [Related]
30. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
[TBL] [Abstract][Full Text] [Related]
31. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.
Russell SM; Johnston JA; Noguchi M; Kawamura M; Bacon CM; Friedmann M; Berg M; McVicar DW; Witthuhn BA; Silvennoinen O
Science; 1994 Nov; 266(5187):1042-5. PubMed ID: 7973658
[TBL] [Abstract][Full Text] [Related]
32. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).
Macchi P; Villa A; Giliani S; Sacco MG; Frattini A; Porta F; Ugazio AG; Johnston JA; Candotti F; O'Shea JJ
Nature; 1995 Sep; 377(6544):65-8. PubMed ID: 7659163
[TBL] [Abstract][Full Text] [Related]
33. Jak-STAT signaling induced by the v-abl oncogene.
Danial NN; Pernis A; Rothman PB
Science; 1995 Sep; 269(5232):1875-7. PubMed ID: 7569929
[TBL] [Abstract][Full Text] [Related]
34. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
[TBL] [Abstract][Full Text] [Related]
35. B-cell differentiation and IL-21 response in
Miggelbrink AM; Logan BR; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Abdel-Azim H; Prockop SE; Shyr D; Decaluwe H; Hanson IC; Gillio A; Dávila Saldaña BJ; Eibel H; Hopkins G; Walter JE; Whangbo JS; Kohn DB; Puck JM; Cowan MJ; Griffith LM; Haddad E; O'Reilly RJ; Notarangelo LD; Pai SY
Blood; 2018 Jun; 131(26):2967-2977. PubMed ID: 29728406
[TBL] [Abstract][Full Text] [Related]
36. Down-modulation of IL-2-triggered JAK3-STAT5 signaling following CD4-ligand binding.
Lowry RP; Goebel J
Transplant Proc; 1999; 31(1-2):820-1. PubMed ID: 10083356
[No Abstract] [Full Text] [Related]
37. Atypical immune phenotype in severe combined immunodeficiency patients with novel mutations in IL2RG and JAK3.
Goldberg L; Simon AJ; Lev A; Barel O; Stauber T; Kunik V; Rechavi G; Somech R
Genes Immun; 2020 Nov; 21(5):326-334. PubMed ID: 32921793
[TBL] [Abstract][Full Text] [Related]
38. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.
Buckley RH; Schiff RI; Schiff SE; Markert ML; Williams LW; Harville TO; Roberts JL; Puck JM
J Pediatr; 1997 Mar; 130(3):378-87. PubMed ID: 9063412
[TBL] [Abstract][Full Text] [Related]
39. IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo.
Recher M; Berglund LJ; Avery DT; Cowan MJ; Gennery AR; Smart J; Peake J; Wong M; Pai SY; Baxi S; Walter JE; Palendira U; Tangye GA; Rice M; Brothers S; Al-Herz W; Oettgen H; Eibel H; Puck JM; Cattaneo F; Ziegler JB; Giliani S; Tangye SG; Notarangelo LD
Blood; 2011 Dec; 118(26):6824-35. PubMed ID: 22039266
[TBL] [Abstract][Full Text] [Related]
40. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases.
Zhang H; Conrad DM; Butler JJ; Zhao C; Blay J; Hoskin DW
J Immunol; 2004 Jul; 173(2):932-44. PubMed ID: 15240680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]